HomeCompareVAIAF vs JNJ

VAIAF vs JNJ: Dividend Comparison 2026

VAIAF yields 1.44% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VAIAF wins by $11.9K in total portfolio value
10 years
VAIAF
VAIAF
● Live price
1.44%
Share price
$51.35
Annual div
$0.74
5Y div CAGR
39.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.2K
Annual income
$7,079.86
Full VAIAF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — VAIAF vs JNJ

📍 VAIAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVAIAFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VAIAF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VAIAF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VAIAF
Annual income on $10K today (after 15% tax)
$122.59/yr
After 10yr DRIP, annual income (after tax)
$6,017.88/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, VAIAF beats the other by $2,031.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VAIAF + JNJ for your $10,000?

VAIAF: 50%JNJ: 50%
100% JNJ50/50100% VAIAF
Portfolio after 10yr
$36.2K
Annual income
$5,884.63/yr
Blended yield
16.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VAIAF
No analyst data
Altman Z
6.7
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VAIAF buys
0
JNJ buys
0
No recent congressional trades found for VAIAF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVAIAFJNJ
Forward yield1.44%2.13%
Annual dividend / share$0.74$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR39.3%28%
Portfolio after 10y$42.2K$30.3K
Annual income after 10y$7,079.86$4,689.40
Total dividends collected$19.7K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VAIAF vs JNJ ($10,000, DRIP)

YearVAIAF PortfolioVAIAF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,901$200.91$10,592$272.30+$309.00VAIAF
2$11,949$285.12$11,289$357.73+$660.00VAIAF
3$13,192$406.88$12,123$472.89+$1.1KVAIAF
4$14,701$584.82$13,141$629.86+$1.6KVAIAF
5$16,578$848.40$14,408$846.81+$2.2KVAIAF
6$18,984$1,245.57$16,021$1,151.60+$3.0KVAIAF
7$22,170$1,856.91$18,122$1,588.22+$4.0KVAIAF
8$26,545$2,823.13$20,930$2,228.20+$5.6KVAIAF
9$32,804$4,400.64$24,792$3,191.91+$8.0KVAIAF
10$42,180$7,079.86$30,274$4,689.40+$11.9KVAIAF

VAIAF vs JNJ: Complete Analysis 2026

VAIAFStock

Vaisala Oyj engages in the weather and environmental, and industrial measurement business serving weather related and industrial markets. The company's products include industrial measurement systems, such as HVAC and indoor air meters, industrial transmitters, power transformer monitoring systems, probes and OEM modules, handheld meters, in-line process refractometers, biogas monitoring systems, liquid measurement systems, and viewLinc continuous monitoring systems. It also provides weather and environmental solutions, such as automatic weather stations, radiosondes and sounding systems, weather and environmental sensors, weather radars, wind lidars, visibility and present weather sensors, ceilometers, lightning sensors, air quality sensors, and road state sensors, as well as pressure, temperature, and humidity sensors; and operates an online store. In addition, the company offers maintenance, calibration and repair, and modernization services, as well as extended warranties and data-based solutions. Vaisala Oyj serves various industrial customers, including data centers, chemicals and allied products, fuel cells, power transformers, semiconductors, automotive, cleanrooms, HVAC and indoor air, warehouses, battery manufacturing, compressed air, life sciences and pharmaceutical, sugar, sweeteners, biogas, and research facilities and metrology; pulp, paper, and wood; food, beverages, and agriculture; and oil and gas refineries, and petrochemicals. It also serves weather-dependent markets mainly meteorology, ground transportation, aviation, maritime, renewable and wind energy, and urban weather and environment. The company has operations in Europe, the Middle East, Africa, North and South Americas, and the Asia Pacific. Vaisala Oyj was founded in 1936 and is headquartered in Vantaa, Finland.

Full VAIAF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VAIAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VAIAF vs SCHDVAIAF vs JEPIVAIAF vs OVAIAF vs KOVAIAF vs MAINVAIAF vs ABBVVAIAF vs MRKVAIAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.